Radiofrequency ablation (RFA) is increasingly being used to treat unresectable liver tumors. Complete ablation of the tumor and a safety margin is necessary to prevent local recurrence.With current electrodes, size and shape of the ablation zone are highly variable leading to unsatisfactory local recurrence rates, especially for tumors > 3 cm. In order to improve Table 6: outcome of the ex vivo bovine liver experiments: comparison according to the number of electrodes activated at the same time.